alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, HS | 1 |
| Pfragner, R | 1 |
| Siegl, V | 1 |
| Ingolic, E | 1 |
| Heintz, E | 1 |
| Schauenstein, K | 1 |
1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Glutamate receptor-mediated effects on growth and morphology of human histiocytic lymphoma cells.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Cell | 2005 |